Knowledge HQ
Publications
Extracellular viral microRNAs as biomarkers of virus infection in human cells
The study identifies viral exmiRs as markers for live virus infection in T cells. Purified T cells were activated and cultured in a G-Rex® 24-well plate.
Publications
High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing
This study profiles CAR T cells across manufacturing. Transductions and expansion were carried out in G-Rex® 6M vessels to support high-density cell growth.
Publications
Efficient and rapid GMP-scalable production of CAR-T and CIK cells
The authors developed an efficient protocol for expanding CAR-T and CIK cells using G-Rex® 24 and G-Rex® 6M devices. The study highlights the scalability and high cell yield obtained using these gas-permeable culture systems.
Publications
Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances
The study reports the optimized GMP-grade manufacturing of TranspoCART19 cells. Following electroporation, cells were expanded for 11 days in G-Rex® 100M devices, achieving high expansion and functionality.
Publications
AI-assisted quantification of tumor-infiltrating lymphocytes in colorectal cancer liver metastasis
This study develops AI models to quantify TILs in colorectal cancer liver metastasis. In the Rapid Expansion Protocol (REP) stage, TILs were cultured in G-Rex® 100 M.
Publications
Detailed analysis of the effects of a NOT gate on activation and growth of T cells
Tmod cells maintain robust potency and selectivity. Transduced cells were cultured in G-Rex® 24 well plates, and T cells for in vivo studies were cultured in G-Rex® 6 well plates.
Publications
Accelerating CAR T cell manufacturing with an automated next-day process
The study presents a 24-hour CAR-T manufacturing workflow. T cell cultures were maintained in G-Rex® vessels during isolation and transduction, and control 7-day expansions were also performed in G-Rex® vessels.
Publications
Cost-effective strategies for CAR-T cell therapy manufacturing
This review discusses cost-effective CAR-T manufacturing. It highlights G-Rex® technology as a main point-of-care (POC) manufacturing platform that enables high cell density production at lower costs compared to fully automated systems.
Publications
A Novel B7-H4xCD3 Bispecific T Cell Engager (PF-07260437) Synergizes with Breast Cancer Standard of Care and Immune-Checkpoint Therapies
PF-07260437 demonstrates potent antitumor efficacy in breast cancer models. For adoptive T cell transfer studies, human T cells were expanded in a G-Rex® cell culture device.
Publications
Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response
This study explores combining CAR T cells with 177Lu-DOTATATE targeted radionuclide therapy. CAR T cells were transduced and subsequently expanded in G-Rex® 6M well plates.
Publications
Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors
The study describes the preclinical evaluation of TAC01-CLDN18.2 T cells. These cells were manufactured using purified CD4/CD8 T cells in a 9-day process utilizing either the G-Rex® system from Wilson Wolf or the Cocoon platform.
Publications
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair
This paper reports a method leveraging HMEJ for Cas9-induced targeted integration of large DNA payloads. In the lentiviral transduction comparison arm, T cells were activated and transferred to a G-Rex® 24-well plate for expansion.